19
Jul

New tools, same goal: Technology akin to GPS apps could enable patients to map out their disease treatment and response

New research projects at the Kuhn-Hicks laboratory aim to develop computational technologies to map cancer evolution and predict treatment response. Through collaboration with the FDA on breast cancer) and funding by the Adelson Medical Research Foundation for multiple myeloma, the goal of these projects is to deploy novel machine learning and spatiotemporal models that would assist clinicians...
Read More
19
Jul

Featured in The Guardian: Fitness trackers could help doctors predict patient’s response to chemotherapy

A recent article in The Guardian highlights research from our lab on how fitness technologies are being used to monitor and predict how patients respond to chemotherapy. Led by Keck School of Medicine’s Dr Jorge Nieva, our clinical collaborator, the work emphasizes the efforts to use fitness trackers as objective measures for patient’s quality of...
Read More
28
Feb

USC Michelson Center for Convergent Bioscience scientists use metal-detection technique to map cancer cells at the molecular level

The Kuhn-Hicks laboratory are using metal-tagged antibodies to map the proteins expressed on cancer cells circulating in the blood and in the bone marrow from a prostate cancer patient.  The study, published in January by Convergent Science Physical Oncology, describes the approach of using an imaging mass cytometer to quantitate and localize 35 different protein markers...
Read More
30
Nov

New Educational Track to Train Undergraduates on Health Innovation to Help Patients Achieve Better Outcomes

USC’s Convergent Science Initiative in Cancer and the USC Jimmy Iovine and Andre Young Academy have developed a new interdisciplinary undergraduate track to launch in the fall of 2019. Students in this new educational track will interact with physicians, scientists, patients and graduate students to develop innovative health solutions. Click here to read more.
13
Oct

Liquid Biopsy for Retinoblastoma

Dr. James Hicks, professor of biologic sciences at the USC Michelson Center for Convergent Bioscience and professor at the Keck School of Medicine at USC, and Liya Xu, a postdoctoral fellow published work showing that the chromosomal changes in the DNA found in the eye’s aqueous humor parallel chromosomal changes found in the retinoblastoma tumor....
Read More
6
Oct

USC’s Global Convergent Science Initiative for a Patient-Centric Approach to Cancer Treatment and Research

Dr.  Peter Kuhn, Dean’s Professor of Biological Sciences and a founding member of the USC Michelson Center for Convergent Bioscience, traveled to Vietnam to discuss a multidisciplinary approach to understanding cancer evolution and forecasting an individual patient’s progress. One goal is to put the cancer patient at the center. Click here to read more.